Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Scott Grimes"'
Autor:
Soumyajit Roy, Scott C. Morgan, Christopher J. D. Wallis, Yilun Sun, Daniel E. Spratt, Julia Malone, Scott Grimes, Dibya Mukherjee, Amar U. Kishan, Fred Saad, Shawn Malone
Publikováno v:
Prostate Cancer and Prostatic Diseases. 26:96-104
Pain is an important dimension of quality-of-life in patients with metastatic castrate-sensitive prostate cancer (mCSPC). However, it is unclear if dynamic change in pain over time can predict for overall survival (OS) or progression-free survival (P
Autor:
Julia Malone, Scott C. Morgan, Robert MacRae, Scott Grimes, Shawn Malone, Daniel E. Spratt, D. Mukherjee, Soumyajit Roy
Publikováno v:
Clinical Oncology. 34:e61-e68
Although health-related quality of life (HR-QoL) outcomes are pivotal in oncology, the prognostic significance of patient-reported HR-QoL metrics is largely undefined in localised prostate cancer. We report the association of baseline HR-QoL metrics
Autor:
Scott C. Morgan, Libni Eapen, Julia Craig, Shawn Malone, Daniel E. Spratt, Scott Grimes, Soumyajit Roy, Julia Malone
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 110:1101-1113
Two phase 3 randomized controlled trials (OTT-0101, RTOG-9413) and a meta-analysis have shown an impact of sequencing of androgen deprivation therapy (ADT) and radiation therapy on oncologic outcomes in prostate cancer (PCa). However, the impact of s
Publikováno v:
Prostate Cancer and Prostatic Diseases. 24:1041-1047
In patients presenting with metastatic prostate cancer, the role of local therapy is evolving. Two recently reported large-scale randomized trials suggest that radiotherapy (RT) directed at the prostate improves overall survival (OS) in patients with
Publikováno v:
Clinical Oncology. 33:181-190
Several classes of concomitant medications have been shown to affect oncological outcomes in patients with prostate cancer (PCa). We assessed the association between the use of commonly prescribed concomitant medications and biochemical relapse-free
Autor:
Soumyajit Roy, Shawn Malone, Daniel E. Spratt, Libni Eapen, Julia Malone, Scott C. Morgan, Julia Craig, Scott Grimes
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 108:1179-1188
We performed a secondary analysis of a phase 3 randomized trial to determine the influence of sequencing of radiation therapy and androgen deprivation therapy (ADT) on posttreatment testosterone recovery and implications of testosterone recovery on s
Autor:
Soumyajit Roy, Yilun Sun, Cristopher J. D. Wallis, Scott C. Morgan, Scott Grimes, Julia Malone, Amar U. Kishan, Dibya Mukherjee, Daniel E. Spratt, Fred Saad, Shawn Malone
Publikováno v:
Prostate cancer and prostatic diseases.
Metastatic castrate sensitive prostate cancer (mCSPC) is a heterogeneous disease state with variable prognosis. Although several life-prolonging systemic agents are available, there is no robust multivariable model to predict prognosis and improve ri
Publikováno v:
Journal of the National Comprehensive Cancer Network. 18:CLO20-047
Autor:
Julie Bowen, Scott C. Morgan, Scott Grimes, Shawn Malone, Choan E, Kyle Malone, Julia Craig, Soumyajit Roy, Rajiv Samant, Robert MacRae, Gad Perry, Libni Eapen
Publikováno v:
Journal of Clinical Oncology. 38:593-601
PURPOSE Dose-escalated radiotherapy (RT) with androgen-deprivation therapy (ADT) is a standard definitive treatment of localized prostate cancer (LPCa). The optimal sequencing of these therapies is unclear. Our phase III trial compared neoadjuvant ve
Autor:
Robert MacRae, Christopher Gualano, Shawn Malone, Daniel E. Spratt, Scott C. Morgan, Fletcher Drogos, Scott Grimes, Michael Zhou, Dibya Mukherjee, Leah A. D'Souza, Soumyajit Roy, Julia Malone
Publikováno v:
International journal of radiation oncology, biology, physics. 112(4)
Both oncologic outcomes and patient-reported outcomes are pivotal in prostate cancer (PCa). However, it remains unknown if there is any association between these 2 outcomes. In this secondary analysis of a randomized controlled trial, we investigated